Gilder Gagnon Howe & CO LLC Beam Therapeutics Inc. Transaction History

Gilder Gagnon Howe & CO LLC

$7.87 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$23.01 - $32.46 $50,552 - $71,314	-2,197 Reduced 2.04%	105,515 $2.54 Million
Q2 2023 Aug 14, 2023	SELL	$29.32 - $35.99 $2,902 - $3,563	-99 Reduced 0.09%	107,712 $3.44 Million
Q1 2023 May 15, 2023	SELL	$30.15 - $48.79 $9,195 - $14,880	-305 Reduced 0.28%	107,811 $3.3 Million
Q4 2022 Feb 14, 2023	SELL	$36.73 - $51.6 $407,886 - $573,018	-11,105 Reduced 9.31%	108,116 $4.23 Million
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $499,603 - $882,812	-12,556 Reduced 9.53%	119,221 $5.68 Million
Q2 2022 Aug 15, 2022	SELL	$29.86 - $62.36 $771,343 - $1.61 Million	-25,832 Reduced 16.39%	131,777 $5.1 Million
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $79,412 - $121,432	1,478 Added 0.95%	157,609 $9.03 Million
Q4 2021 Feb 14, 2022	BUY	$68.02 - $99.06 $311,871 - $454,190	4,585 Added 3.03%	156,131 $12.4 Million
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $618,178 - $978,887	7,327 Added 5.08%	151,546 $13.2 Million
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $20,454 - $41,058	319 Added 0.22%	144,219 $18.6 Million
Q1 2021 May 17, 2021	BUY	$71.28 - $120.75 $1.01 Million - $1.71 Million	14,189 Added 10.94%	143,900 $11.5 Million
Q4 2020 Feb 16, 2021	BUY	$22.24 - $95.63 $521,483 - $2.24 Million	23,448 Added 22.07%	129,711 $10.6 Million
Q3 2020 Nov 16, 2020	BUY	$19.0 - $30.57 $288,002 - $463,380	15,158 Added 16.64%	106,263 $2.62 Million
Q2 2020 Aug 14, 2020	BUY	$15.26 - $28.66 $19,715 - $37,028	1,292 Added 1.44%	91,105 $2.55 Million
Q1 2020 May 15, 2020	BUY	$13.31 - $29.2 $1.2 Million - $2.62 Million	89,813 New	89,813 $1.62 Million

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

Farallon Capital Management LLC San Francisco, CA

8.21M
Shares

$208 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.84M
Shares

$198 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.63M
Shares

$193 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

6.53M
Shares

$165 Million
1.52% of portfolio
Arch Venture Management, LLC Chicago, IL

4.83M
Shares

$122 Million
71.21% of portfolio

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account